Related Experiment Videos

[Drug-induced pulmonary lesions]

D Dragomir1, V Popescu

  • 1Clinica de Pediatrie, Spitalul Clinic Sf.Pantelimon, Bucureşti.

Pediatrie (Bucharest, Romania)
|July 1, 1992
PubMed

Insights

Drug-induced lung damage from cytotoxic and non-cytotoxic medications is a developing area in pathology. This review covers pathogenic mechanisms, histopathology, clinical features, and treatment of drug-induced pulmonary toxicity.

Area of Science:

  • Pathology
  • Toxicology
  • Pulmonology

Context:

  • Drug-induced pulmonary toxicity is a significant clinical challenge.
  • Understanding the mechanisms and manifestations is crucial for patient care.
  • This field requires further delineation and research.

Purpose:

  • To discuss drug-induced pulmonary toxicity (cytotoxic and non-cytotoxic drugs).
  • To present essential pathogenic mechanisms and histopathological lesions.
  • To review clinical, radiological aspects, treatment, evolution, and prognosis.

Summary:

  • Essential pathogenic mechanisms and histopathological lesions, including interstitial pneumonia and pulmonary fibrosis, are presented.
  • Lesional aspects specific to certain drugs are reviewed.
  • Clinical, radiological aspects, treatment, evolution, and prognosis of drug-induced pulmonary disease are detailed.

Impact:

  • Provides a comprehensive overview of drug-induced lung disease.
  • Aids in the diagnosis and management of patients with pulmonary toxicity.
  • Highlights the need for further research in this complex area.

Related Concept Videos